Your browser doesn't support javascript.
loading
Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.
Fang, Wenfeng; Jin, Haoxuan; Zhou, Huaqiang; Hong, Shaodong; Ma, Yuxiang; Zhang, Yaxiong; Su, Xiaofan; Chen, Longyun; Yang, Yunpeng; Xu, Shengqiang; Liao, Yuwei; He, Yuming; Zhao, Hongyun; Huang, Yan; Gao, Zhibo; Zhang, Li.
Afiliación
  • Fang W; Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong
  • Jin H; Cancer Research Institute of YuceBio, Shenzhen, China.
  • Zhou H; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Hong S; Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong
  • Ma Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong
  • Zhang Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong
  • Su X; Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong
  • Chen L; Cancer Research Institute of YuceBio, Shenzhen, China.
  • Yang Y; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Xu S; Cancer Research Institute of YuceBio, Shenzhen, China.
  • Liao Y; YuceBio Technology Co., Ltd., Shenzhen, China.
  • He Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong
  • Zhao H; Cancer Research Institute of YuceBio, Shenzhen, China.
  • Huang Y; YuceBio Technology Co., Ltd., Shenzhen, China.
  • Gao Z; Yangjiang Key Laboratory of Respiratory Diseases, Yangjiang People's Hospital, Yangjiang, China.
  • Zhang L; YuceBio Technology Co., Ltd., Shenzhen, China.
Mol Cancer ; 20(1): 37, 2021 02 23.
Article en En | MEDLINE | ID: mdl-33622313
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Heterogeneidad Genética / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Heterogeneidad Genética / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article